Advertisement
Advertisement

ROIV

ROIV logo

Roivant Sciences Ltd. Common Shares

21.61
USD
Sponsored
-0.41
-1.87%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

21.61

0.00
+0.01%

ROIV Earnings Reports

Positive Surprise Ratio

ROIV beat 9 of 17 last estimates.

53%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Roivant Sciences Ltd. Common Shares earnings per share and revenue

On Nov 10, 2025, ROIV reported earnings of -0.17 USD per share (EPS) for Q2 26, beating the estimate of -0.34 USD, resulting in a 50.15% surprise. Revenue reached 1.57 million, compared to an expected 7.09 million, with a -77.83% difference. The market reacted with a +2.67% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q2 2026, Roivant Sciences Ltd. Common Shares reported EPS of -$0.17, beating estimates by 50.15%, and revenue of $1.57M, -77.83% below expectations.
The stock price moved up 2.67%, changed from $20.62 before the earnings release to $21.17 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Roivant Sciences Ltd. Common Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement